REQUEST A DEMO
Total
USD $0.00
Search more companies

Kfn Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Livestock Merchant Wholesalers | Medical Laboratories
Full name: Kfn Pharma Sdn. Bhd. Profile Updated: May 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Kfn Pharma Sdn. Bhd. is based in Malaysia, with the head office in Kuching. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on December 19, 2019. The latest financial highlights indicate a net sales revenue increase of 35.89% in 2025. Over the same period, its total assets grew by 38.54%. The enterprise’s net profit margin decreased by 3.25% in 2025.

Legal Address
1St Floor, Lot 109,Jalan Datuk Abang Haji Abdul Rahim
Kuching; Sarawak; Postal Code: 93450

Contact Details: Purchase the Kfn Pharma Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Kfn Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
December 19, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Kfn Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
35.89%▲
Total Operating Revenue
35.89%▲
Operating Profit
-37.59%▼
Net Profit/Loss for the Period
-48.72%▼
Total Assets
38.54%▲
Total Equity
25.37%▲
Operating Profit Margin
-3.19%▼
Net Profit Margin
-3.25%▼
Return on Equity (ROE)
-29.24%▼
Quick Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?